ArkVax
PrivateLast Round
Seed
Dec 5, 2022
Total Funding Raised
$13,000
Company Overview
ArkVax is a biotechnology company that develops recombinant glycoconjugate vaccines for animals through glycoengineering.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
glycoconjugate vaccineanimal healthbacterial engineeringrecombinant vaccineveterinary biotechnologyglycoengineeringlivestock healthvaccine platformantimicrobial resistancebiotech startupanimal pharmavaccine tech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArkVax Comparables
Compare ArkVax with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Malcisbo AG | 85% | |
| Scaffold Biotech | 77% | |
| The Vaccine Group | 77% | |
ArkVax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 5, 2022 | ||||
| Accelerator | Sep 21, 2020 |
ArkVax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Future Planet Capital Regional | Seed |
| Start Codon | Seed |
| Accelerate@Babraham | Accelerator |
| UK Innovation & Science Seed Fund | Seed |
ArkVax Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ArkVax's valuation, stock price, and market status.